MedTrace Logo

Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

NCT04843917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-09-22

No results posted yet for this study

Summary

Vaccination against coronavirus disease 19 (COVID-19) is an essential primary prevention tool to limit the health and economic effects of the pandemic. Objectives: To determine the variation in the levels of Immunoglobulin G (IgG) antibodies in health workers who received a COVID-19 vaccine.

Conditions

  • Coronavirus 2019
  • Healthcare Workers
  • Vaccine

Interventions

DIAGNOSTIC_TEST

Immunoglobulin G detection

Detection of immunoglobulin G against Spike Receptor Binding Domain against severe acute respiratory syndrome coronavirus 2

Sponsors & Collaborators

  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • vanina Pagotto, MSC · Hospital Italiano de Buenos Aires

  • Silvana Figar, MSC · Hospital Italiano de Buenos Aires

  • Hernán Garcia Rivello, Pharm · Hospital Italiano de Buenos Aires

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-09
Primary Completion
2023-06-09
Completion
2023-08-09

Countries

  • Argentina

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04843917 on ClinicalTrials.gov